Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S451-S473 , July 2009

Reporting Standards for Angioplasty and Stent-assisted Angioplasty for Intracranial Atherosclerosis

  • H. Christian Schumacher, MD

      Affiliations

    • Saul R. Korey Department of Neurology, Division of Vascular Neurology and Neurocritical Care, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Philip M. Meyers, MD, FAHA

      Affiliations

    • Columbia University, College of Physicians and Surgeons, Neurological Institute of New York, NY
    • Corresponding Author InformationAddress correspondence to Philip M. Meyers, MD, FAHA, Associate Professor, Radiology and Neurological Surgery, Columbia University, College of Physicians & Surgeons, Clinical Director, Neuroendovascular Service, New York Presbyterian–Columbia Neurological Institute, New York, NY 10032
    • ,
  • Randall T. Higashida, MD

      Affiliations

    • University of California, San Francisco
    • ,
  • Colin P. Derdeyn, MD

      Affiliations

    • Mallinckrodt Institute of Radiology, Washington University, School of Medicine, St. Louis, Missouri
    • ,
  • Sean D. Lavine, MD

      Affiliations

    • Columbia University, College of Physicians and Surgeons, Neurological Institute of New York, NY
    • ,
  • Gary M. Nesbit, MD

      Affiliations

    • Oregon Health and Science University, Portland
    • ,
  • David Sacks, MD

      Affiliations

    • Advanced Interventional Radiology, Reading Hospital and Medical Center, Reading, Pennsylvania
    • ,
  • Peter Rasmussen, MD

      Affiliations

    • Cleveland Clinic Foundation, Ohio
    • ,
  • Lawrence R. Wechsler, MD

      Affiliations

    • University of Pittsburgh Medical Center, Pennsylvania

Received 31 May 2008 ,Revised 27 October 2008 ,Accepted 4 November 2008.

References 

  1. Schumacher HC, Meyers PM, Mohr JP, Higashida R. Elective angioplasty and stenting for intracranial atherosclerosis. In:  Al-Mubarak N,  Rubin GS,  Iyer SS,  Vitek JJ editor. Carotid Artery Stenting: Current Practice and Techniques. New York: Lippincott; 2003;
  2. SSYLVIA Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388–1392
  3. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses (The Wing Span Study). Stroke. 2007;38:1531–1537
  4. Higashida RT, Meyers PM, Connors JJ, Sacks D, Strother CM, Barr JD, et al. Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2005;26:2323–2327
  5. SAMMPRIS. Stenting vs Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis. http://clinicaltrials.gov/ct2/show/NCT00576693?term=SAMMPRIS&rank=1Accessed October 26, 2008
  6. Kremer C, Schaettin T, Georgiadis D, Baumgartner RW. Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry. 2004;75:1300–1303
  7. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–65
  8. Stineman MG, Shea JA, Jette A, Tassoni CJ, Ottenbacher KJ, Fiedler R, et al. The Functional Independence Measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil. 1996;77:1101–1108
  9. de Haan R, Limburg M, Bossuyt P, van der MJ, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke. 1995;26:2027–2030
  10. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–870
  11. The Internet Stroke Center. Stroke Scales & Clinical Assessment Tools. www.strokecenter.org/trials/scales/scales-overview.htmAccessed October 26, 2008
  12. National Institute of Neurological Disorders and Stroke. NIH Stroke Scale Training. www.ninds.nih.gov/doctors/stroke_scale_training.htmAccessed October 26, 2008
  13. Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33:2243–2246
  14. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, et al. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588–600
  15. Naritomi H, Sawada T, Kuriyama Y, Kinugawa H, Kaneko T, Takamiya M. Effect of chronic middle cerebral artery stenosis on the local cerebral hemodynamics. Stroke. 1985;16:214–219
  16. Derdeyn CP, Powers WJ, Grubb RL. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol. 1998;19:1463–1469
  17. Castaigne P, Lhermitte F, Gautier JC, Escourolle R, Derouesne C, Der AP, et al. Arterial occlusions in the vertebro-basilar system (A study of 44 patients with post-mortem data). Brain. 1973;96:133–154
  18. Constantinides P. Pathogenesis of cerebral artery thrombosis in man. Arch Pathol. 1967;83:422–428
  19. Lhermitte F, Gautier JC, Derouesne C. Nature of occlusions of the middle cerebral artery. Neurology. 1970;20:82–88
  20. Ogata J, Masuda J, Yutani C, Yamaguchi T. Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry. 1994;57:17–21
  21. Sadoshima S, Fukushima T, Tanaka K. Cerebral artery thrombosis and intramural hemorrhage. Stroke. 1979;10:411–414
  22. Hinton RC, Mohr JP, Ackerman RH, Adair LB, Fisher CM. Symptomatic middle cerebral artery stenosis. Ann Neurol. 1979;5:152–157
  23. Corston RN, Kendall BE, Marshall J. Prognosis in middle cerebral artery stenosis. Stroke. 1984;15:237–241
  24. Koroshetz WJ, Ropper AH. Artery-to-artery embolism causing stroke in the posterior circulation. Neurology. 1987;37:292–295
  25. Masuda J, Ogata J, Yutani C, Miyashita T, Yamaguchi T. Artery-to-artery embolism from a thrombus formed in stenotic middle cerebral artery (Report of an autopsy case). Stroke. 1987;18:680–684
  26. Segura T, Serena J, Castellanos M, Teruel J, Vilar C, Davalos A. Embolism in acute middle cerebral artery stenosis. Neurology. 2001;56:497–501
  27. Wong KS, Gao S, Lam WW, Chan YL, Kay R. A pilot study of microembolic signals in patients with middle cerebral artery stenosis. J Neuroimaging. 2001;11:137–140
  28. Fisher CM, Caplan LR. Basilar artery branch occlusion: a cause of pontine infarction. Neurology. 1971;21:900–905
  29. Fisher CM. Bilateral occlusion of basilar artery branches. J Neurol Neurosurg Psychiatry. 1977;40:1182–1189
  30. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke. 1986;17:1112–1120
  31. Caplan L, Babikian V, Helgason C, Hier DB, DeWitt D, Patel D, et al. Occlusive disease of the middle cerebral artery. Neurology. 1985;35:975–982
  32. Lyrer PA, Engelter S, Radu EW, Steck AJ. Cerebral infarcts related to isolated middle cerebral artery stenosis. Stroke. 1997;28:1022–1027
  33. Mull M, Schwarz M, Thron A. Cerebral hemispheric low-flow infarcts in arterial occlusive disease (Lesion patterns and angiomorphological conditions). Stroke. 1997;28:118–123
  34. Felberg RA, Christou I, Demchuk AM, Malkoff M, Alexandrov AV. Screening for intracranial stenosis with transcranial Doppler: the accuracy of mean flow velocity thresholds. J Neuroimaging. 2002;12:9–14
  35. Hirai T, Korogi Y, Ono K, Nagano M, Maruoka K, Uemura S, et al. Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol. 2002;23:93–101
  36. Bash S, Villablanca JP, Jahan R, Duckwiler G, Tillis M, Kidwell C, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005;26:1012–1021
  37. Willinek WA, von Falkenhausen M, Born M, Gieseke J, Holler T, Klockgether T, et al. Noninvasive detection of steno-occlusive disease of the supra-aortic arteries with three-dimensional contrast-enhanced magnetic resonance angiography: a prospective, intra-individual comparative analysis with digital subtraction angiography. Stroke. 2005;36:38–43
  38. Wright VL, Olan W, Dick B, Yu H, Alberts-Grill N, Latour LL, et al. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology. 2005;65:27–32
  39. Villablanca JP, Nael K, Habibi R, Nael A, Laub G, Finn JP. 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography. Invest Radiol. 2006;41:799–805
  40. Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial. Neurology. 2007;68:2099–2106
  41. Derdeyn CP, Grubb RL, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251–259
  42. Furukawa M, Kashiwagi S, Matsunaga N, Suzuki M, Kishimoto K, Shirao S. Evaluation of cerebral perfusion parameters measured by perfusion CT in chronic cerebral ischemia: comparison with xenon CT. J Comput Assist Tomogr. 2002;26:272–278
  43. Kikuchi K, Murase K, Miki H, Kikuchi T, Sugawara Y, Mochizuki T, et al. Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease. AJNR Am J Neuroradiol. 2001;22:248–254
  44. Kim JH, Lee SJ, Shin T, Kang KH, Choi PY, Kim JH, et al. Correlative assessment of hemodynamic parameters obtained with T2*- weighted perfusion MR imaging and SPECT in symptomatic carotid artery occlusion. AJNR Am J Neuroradiol. 2000;21:1450–1456
  45. Lythgoe DJ, Williams SC, Cullinane M, Markus HS. Mapping of cerebrovascular reactivity using BOLD magnetic resonance imaging. Magn Reson Imaging. 1999;17:495–502
  46. Lythgoe DJ, Ostergaard L, William SC, Cluckie A, Buxton-Thomas M, Simmons A, et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2000;18:1–11
  47. Ozgur HT, Kent WT, Masaryk A, Seeger JF, Williams W, Krupinski E, et al. Correlation of cerebrovascular reserve as measured by acetazolamide- challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol. 2001;22:928–936
  48. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology. 2000;55:490–497
  49. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–1316
  50. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555–563
  51. Gupta R, Schumacher HC, Mangla S, Meyers PM, Duong H, Khandji AG, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology. 2003;61:1729–1735
  52. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses (The WingSpan Study). Stroke. 2007;38:1531–1537
  53. US Food and Drug Administration. WingSpan Stent System and Gateway PTA Balloon Catheter (Summary of Safety and Probable Benefit). www.fda.gov/cdrh/pdf5/h050001b.pdfAccessed October 26, 2008
  54. Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry. 2004;75:847–851
  55. Rothwell PM, Gibson RJ, Slattery J, Sellar RJ, Warlow CP European Carotid Surgery Trialists' Collaborative Group. Equivalence of measurements of carotid stenosis (A comparison of three methods on 1001 angiograms). Stroke. 1994;25:2435–2439
  56. Rothwell PM, Gibson RJ, Slattery J, Warlow CP European Carotid Surgery Trialists' Collaborative Group. Prognostic value and reproducibility of measurements of carotid stenosis (A comparison of three methods on 1001 angiograms). Stroke. 1994;25:2440–2444
  57. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  58. Yokote H, Terada T, Ryujin K, Konoshita Y, Tsuura M, Nakai E, et al. Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. Neuroradiology. 1998;40:590–596
  59. Weber W, Mayer TE, Henkes H, Kis B, Hamann GF, Schulte-Altedorneburg G, et al. Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol. 2005;55:231–236
  60. Lee TH, Kim DH, Lee BH, Kim HJ, Choi CH, Park KP, et al. Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol. 2005;26:166–174
  61. Straube T, Stingele R, Jansen O. Primary stenting of intracranial atherosclerotic stenoses. Cardiovasc Intervent Radiol. 2005;28:289–295
  62. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643–646
  63. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, et al. Angioplasty for symptomatic intracranial stenosis (Clinical outcome). Stroke. 2006;37:1016–1020
  64. Bartlett ES, Walters TD, Symons SP, Fox AJ. Quantification of carotid stenosis on CT angiography. AJNR Am J Neuroradiol. 2006;27:13–19
  65. Bartlett ES, Symons SP, Fox AJ. Correlation of carotid stenosis diameter and cross-sectional areas with CT angiography. AJNR Am J Neuroradiol. 2006;27:638–642
  66. Bartlett ES, Walters TD, Symons SP, Fox AJ. Carotid stenosis index revisited with direct CT angiography measurement of carotid arteries to quantify carotid stenosis. Stroke. 2007;38:286–291
  67. Yamura M, Hirai T, Korogi Y, Ikushima I, Yamashita Y. Quantitative evaluation of measurement accuracy for three-dimensional angiography system using various phantoms. Radiat Med. 2005;23:175–181
  68. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19:1525–1533
  69. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology. 1997;39:111–116
  70. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004;35:1375–1380
  71. Chaturvedi S, St Pierre ME, Bertasio B. Cerebral angioplasty practice at major medical centers in the United States. Neuroradiology. 2000;42:218–220
  72. Hobson RW II, Howard VJ, Roubin GS, Ferguson RD, Brott TG, Howard G, et al. Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg. 2004;40:952–957
  73. Featherstone RL, Brown MM, Coward LJ. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis. 2004;18:69–74
  74. EVA-3S Trialists. Endarterectomy vs Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. Cerebrovasc Dis. 2004;18:62–65
  75. Connors JJ, Sacks D, Furlan AJ, Selman WR, Russell EJ, Stieg PE, et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the Am Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology. J Vasc Interv Radiol. 2004;15:1347–1356
  76. Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ. Cost analysis of 'bridging therapy' with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol. 2004;93:509–511
  77. Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest. 2004;125:1642–1650
  78. Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost. 2006;4:1246–1252
  79. Beldi G, Beng L, Siegel G, Bisch-Knaden S, Candinas D. Prevention of perioperative thromboembolism in patients with atrial fibrillation. Br J Surg. 2007;94:1351–1355
  80. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328–2334
  81. Liu R, Nair D, Ix J, Moore DH, Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy (A systematic review and meta-analysis). J Gen Intern Med. 2005;20:193–200
  82. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–337
  83. Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol. 1997;18:1661–1668
  84. Connors JJ, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91:415–423
  85. Jiang WJ, Du B, Leung TW, Xu XT, Wang YL, Wang YJ, et al. Cerebrovascular complications of stent-assisted angioplasty in symptomatic intracranial arterial stenosis. [abstract P72] Stroke. 2006;37:
  86. Kim DJ, Lee BH, Kim DI, Shim WH, Jeon P, Lee TH. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol. 2005;26:1381–1388
  87. Gress DR, Smith WS, Dowd CF, Van H, Finley RJ, Higashida RT. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. V Neurosurgery. 2002;51:23–27
  88. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology. 2005;47:222–228
  89. Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J. The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol. 2005;26:2342–2348
  90. Dorros G, Cohn JM, Palmer LE. Stent deployment resolves a petrous carotid artery angioplasty dissection. AJNR Am J Neuroradiol. 1998;19:392–394
  91. Jaeger HJ, Mathias KD, Drescher R, Hauth E, Bockisch G, Demirel E, et al. Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. AJNR Am J Neuroradiol. 2001;22:1251–1259
  92. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol. 2002;23:430–436
  93. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C. Endovascular reconstruction of intracranial arteries by stent placement and combined techniques. J Neurosurg. 2002;97:1306–1313
  94. Levy EI, Boulos AS, Guterman LR. Stent-assisted endoluminal revascularization for the treatment of intracranial atherosclerotic disease. Neurol Res. 2002;24:337–346
  95. Levy EI, Hanel RA, Boulos AS, Bendok BR, Kim SH, Gibbons KJ, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg. 2003;99:653–660
  96. Qureshi AI, Suri MF, Siddiqui AM, Kim SH, Boulos AS, Ringer AJ, et al. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2005;15:240–249
  97. Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg. 2002;97:1294–1301
  98. McKenzie JD, Wallace RC, Dean BL, Flom RA, Khayata MH. Preliminary results of intracranial angioplasty for vascular stenosis caused by atherosclerosis and vasculitis. AJNR Am J Neuroradiol. 1996;17:263–268
  99. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30:1065–1069
  100. Nahser HC, Henkes H, Weber W, Berg-Dammer E, Yousry TA, Kuhne D. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol. 2000;21:1293–1301
  101. Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916–1919
  102. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after percutaneous transluminal cerebral angioplasty. Eur Radiol. 1998;8:403–408
  103. Mori T, Kazita K, Chokyu K, Mima T, Mori K. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol. 2000;21:249–254
  104. van Mook WN, Rennenberg RJ, Schurink GW, van Oostenbrugge RJ, Mess WH, Hofman PA, et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005;4:877–888
  105. Kaku Y, Yoshimura S, Kokuzawa J. Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004;25:1403–1408
  106. Gossetti B, Martinelli O, Guerricchio R, Irace L, Benedetti-Valentini F. Transcranial Doppler in 178 patients before, during, and after carotid endarterectomy. J Neuroimaging. 1997;7:213–216
  107. Dalman JE, Beenakkers IC, Moll FL, Leusink JA, Ackerstaff RG. Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg. 1999;18:222–227
  108. Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, et al. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000;47:335–343
  109. Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv. 2007;69:690–696
  110. Eckard DA, Zarnow DM, McPherson CM, Siegel EL, Eckard VR, Batnitzky S, et al. Intracranial internal carotid artery angioplasty: technique with clinical and radiographic results and follow-up. AJR Am J Roentgenol. 1999;172:703–707
  111. Malek AM, Higashida RT, Phatouros CC, Lempert TE, Meyers PM, Gress DR, et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke. 1999;30:2073–2085
  112. Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol. 1999;20:787–789
  113. Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JI, Charbel F. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol. 2000;57:1625–1630
  114. Gomez CR, Misra VK, Campbell MS, Soto RD. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol. 2000;21:971–973
  115. Gomez CR, Misra VK, Liu MW, Wadlington VR, Terry JB, Tulyapronchote R, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke. 2000;31:95–99
  116. Rasmussen PA, Perl J, Barr JD, Markarian GZ, Katzan I, Sila C, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg. 2000;92:771–778
  117. Levy EI, Horowitz MB, Koebbe CJ, Jungreis CC, Pride GL, Dutton K, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery. 2001;48:1215–1221
  118. Ramee SR, Dawson R, McKinley KL, Felberg R, Collins TJ, Jenkins JS, et al. Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv. 2001;52:457–467
  119. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36:e165–e168
  120. Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res. 2005;27:S95–S102
  121. Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol. 2005;26:869–874
  122. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol. 2005;26:525–530
  123. Suh DC, Kim SJ, Lee DH, Kim W, Choi CG, Lee JH, et al. Outcome of endovascular treatment in symptomatic intracranial vascular stenosis. Korean J Radiol. 2005;6:1–7
  124. Tsumoto T, Terada T, Tsuura M, Matsumoto H, Masuo O, Yamaga H, et al. Diffusion-weighted imaging abnormalities after percutaneous transluminal angioplasty and stenting for intracranial atherosclerotic disease. AJNR Am J Neuroradiol. 2005;26:385–389
  125. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, et al. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology. 2005;237:620–626
  126. Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology. 2005;64:1055–1057
  127. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66:1187–1191
  128. Terada T, Tsuura M, Matsumoto H, Masuo O, Tsumoto T, Yamaga H, et al. Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenoses. Neurosurgery. 2006;59:310–318
  129. de Rochemont Rdu M, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents—initial experience. Radiology. 2004;231:45–49
  130. Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS. Intracranial angioplasty and stenting in the awake patient. J Neuroimaging. 2006;16:216–223
  131. Bando K, Satoh K, Matsubara S, Nakatani M, Nagahiro S. Hyperperfusion phenomenon after percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial vertebral artery (Case report). J Neurosurg. 2001;94:826–830
  132. Gahn G, Richter A, Bourquain H, Hallmeyer S, Riechmann H, von Kummer R. Cerebrovascular reserve before and after vertebral artery angioplasty. AJNR Am J Neuroradiol. 1999;20:785–786
  133. Stehbens WE. Pathology of Cerebral Blood Vessels. St Louis: Mosby; 1972;
  134. Ross MH, Romrell LJ, Kaye GI. Histology: A Text and Atlas. Baltimore: Williams & Wilkins; 1995;
  135. Monson KL, Goldsmith W, Barbaro NM, Manley GT. Axial mechanical properties of fresh human cerebral blood vessels. J Biomech Eng. 2003;125:288–294
  136. Tanriover N, Kawashima M, Rhoton AL, Ulm AJ, Mericle RA. Microsurgical anatomy of the early branches of the middle cerebral artery: morphometric analysis and classification with angiographic correlation. J Neurosurg. 2003;98:1277–1290
  137. Canham PB, Finlay HM, Dixon JG, Boughner DR, Chen A. Measurements from light and polarised light microscopy of human coronary arteries fixed at distending pressure. Cardiovasc Res. 1989;23:973–982
  138. Holzapfel GA, Sommer G, Gasser CT, Regitnig P. Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling. Am J Physiol Heart Circ Physiol. 2005;289:H2048–H2058
  139. Walmsley JG, Campling MR, Chertkow HM. Interrelationships among wall structure, smooth muscle orientation, and contraction in human major cerebral arteries. Stroke. 1983;14:781–790
  140. Busby DE, Burton AC. The effect of age on the elasticity of the major brain arteries. Can J Physiol Pharmacol. 1965;43:185–202
  141. Hayashi K, Nagasawa S, Naruo Y, Okumura A, Moritake K, Handa H. Mechanical properties of human cerebral arteries. Biorheology. 1980;17:211–218
  142. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881–887
  143. Al-Mubarak N, Gomez CR, Vitek JJ, Roubin GS. Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol. 1998;19:1949–1951
  144. US Food and Drug Administration. WingSpan Stent System and Gateway PTA Balloon Catheter. Humanitarian Exception Device Approval Letter, August 3, 2005 www.fda.gov/cdrh/pdf5/h050001a.pdfAccessed October 26, 2008
  145. Hahnel S, Ringleb P, Hartmann M. Treatment of intracranial stenoses using the Neuroform stent system: initial experience in five cases. Neuroradiology. 2006;48:479–485
  146. Lee SH, Jung JH, Shim WH. Endovascular treatment of basilar artery stenosis with drug-eluting stent: a case report and literature review. Catheter Cardiovasc Interv. 2005;64:296–300
  147. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37:2562–2566
  148. Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044–1051discussion 1051
  149. US Food and Drug Administration. FDA Statement on Coronary Drug-Eluting Stents, September 14, 2006. www.fda.gov/cdrh/news/091406.htmlAccessed October 26, 2008
  150. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl 6):110S–112S
  151. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions (The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology). Eur Heart J. 2005;26:804–847
  152. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–168
  153. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial (Phase I findings). N Engl J Med. 1985;312:932–936
  154. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke (The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism). JAMA. 1999;282:2003–2011
  155. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109–e137
  156. Shigeyama J, Ito S, Kondo H, Ito O, Matsushita T, Okamoto M, et al. Angiographic classification of coronary dissections after plain old balloon angioplasty for prediction of regression at follow-up. Jpn Heart J. 2001;42:393–408
  157. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, et al Guidelines for the management of aneurysmal subarachnoid hemorrhage (A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association). Circulation. 1994;90:2592–2605
  158. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116:e391–e413
  159. US Food and Drug Administration. WingSpan Stent System and Gateway PTA Balloon Catheter (Summary of Safety and Probable Benefit). www.fda.gov/cdrh/pdf5/h050001b.pdfAccessed March 4, 2005
  160. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack—proposal for a new definition. N Engl J Med. 2002;347:1713–1716
  161. The National Institute of Neurological Disorders rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke (The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group). N Engl J Med. 1995;333:1581–1587
  162. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke (The European Cooperative Acute Stroke Study (ECASS)). JAMA. 1995;274:1017–1025
  163. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) (Second European–Australasian Acute Stroke Study Investigators). Lancet. 1998;352:1245–1251
  164. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?. Stroke. 2001;32:1330–1335
  165. Liu AY, Do HM, Albers GW, Lopez JR, Steinberg GK, Marks MP. Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. AJNR Am J Neuroradiol. 2001;22:1597–1601
  166. Rezende MT, Spelle L, Mounayer C, Piotin M, Abud DG, Moret J. Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke. 2006;37:e12–e14
  167. Schoser BG, Heesen C, Eckert B, Thie A. Cerebral hyperperfusion injury after percutaneous transluminal angioplasty of extracranial arteries. J Neurol. 1997;244:101–104
  168. McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke. 1999;30:2483–2486
  169. Phatouros CC, Lefler JE, Higashida RT, Meyers PM, Malek AM, Dowd CF, et al. Primary stenting for high-grade basilar artery stenosis. AJNR Am J Neuroradiol. 2000;21:1744–1749
  170. Callahan AS, Berger BL. Balloon angioplasty of intracranial arteries for stroke prevention. J Neuroimaging. 1997;7:232–235
  171. Barakate MS, Snook KL, Harrington TJ, Sorby W, Pik J, Morgan MK. Angioplasty and stenting in the posterior cerebral circulation. J Endovasc Ther. 2001;8:558–565
  172. Terada T, Nakai E, Tsuura M, Nakai K, Itakura T. Combined surgery and endovascular stenting for basilar artery stenosis refractory to balloon angioplasty: technical case report. Acta Neurochir (Wien). 2001;143:511–516
  173. Lee JH, Kwon SU, Suh DC, Kim JS. Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long-term follow-up. Cerebrovasc Dis. 2003;15:90–97
  174. Zhang QZ, Miao ZR, Li SM, Zhu FS, Hua Y, Wang ML, et al. Complications of stent-assistant angioplasty of symptomatic intracranial artery stenosis [in Chinese]. Zhonghua Yi Xue Za Zhi. 2003;83:1402–1405
  175. Matsumaru Y, Tsuruta W, Takigawa T, Hyodo A, Sato H, Matsumura A. Percutaneous transluminal angioplasty for atherosclerotic stenoses of intracranial vessels. Interv Neuroradiol. 2004;10:17–20
  176. Liu JM, Hong B, Huang QH, Xu Y, Zhao WY, Zhang L, et al. Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis [in Chinese]. Zhonghua Wai Ke Za Zhi. 2004;42:169–172
  177. Lylyk P, Vila JF, Miranda C, Ferrario A, Musacchio A, Rufenacht D, et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res. 2005;27(suppl 1):S84–S88
  178. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68:420–426
  179. Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, et al. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol. 2007;68:378–386
  180. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery. 2007;61:236–242discussion 242–243

 Dr Higashida served as a consultant to Cordis Neurovascular. Dr Nesbit received honoraria from Cordis Neurovascular and Genentech, has an ownership interest in Concentric Medical, and served as a consultant to Concentric Medical. Dr Wechsler served as a consultant to Nuevelo, Inc, and Abbott Vascular. Dr Lavine received honoraria from Cordis Neurovascular. Dr Rasmussen received honoraria from the Universities of Minnesota and Pittsburgh, Microvention/Terumo, ev3, Possis, Medical/Medrad, and Micrus, has an ownership interest in Chestnut Medical, and served as a consultant to Chestnut Medical.

 Published in Stroke. 2009;40(5):e348–e365.Published online before print February 26, 2009, doi: 10.1161/STROKEAHA.108.527580.

PII: S1051-0443(09)00219-X

doi: 10.1016/j.jvir.2009.03.005

Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S451-S473 , July 2009

Article Tools

* Image Usage & Resolution